Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catlow

Showing results (351-360 of 363) with videos related to

Pageof 37
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Faraday Discussions|August 11, 2018
Theory as a driving force to understand reactions on nanoparticles: general discussionRosa Arrigo, Kassim Badmus, Francesca Baletto, et al.
Faraday Discussions|June 22, 2016
Designing new catalysts: synthesis of new active structures: general discussionParasuraman Selvam, Joachim Sauer, Bruce Garrett, et al.
Faraday Discussions|July 6, 2021
Thermal catalytic conversion: general discussionKaty Armstrong, Sergio Barbarino, Xiangkun Elvis Cao, et al.
Faraday Discussions|August 10, 2018
Control of catalytic nanoparticle synthesis: general discussionAldiar Adishev, Rosa Arrigo, Francesca Baletto, et al.
Faraday Discussions|June 26, 2023
Heterogeneous catalytic and chemical looping routes to N<sub>2</sub> activation: general discussionFatima Abi Ghaida, Katharina Brinkert, Yongli Cai, et al.
Faraday Discussions|June 29, 2023
Electrocatalytic and photocatalytic routes to N<sub>2</sub> activation: general discussionSuchi Biswas, Katharina Brinkert, Richard A Catlow, et al.
Journal of Medicinal Chemistry|January 21, 2015
Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structuresJames A Monn, Lourdes Prieto, Lorena Taboada, et al.
Faraday Discussions|April 20, 2017
Designing new catalysts for synthetic fuels: general discussionKatherine Holt, Linda Jewell, Hans Niemantsverdriet, et al.
Faraday Discussions|August 11, 2018
The challenges of characterising nanoparticulate catalysts: general discussionRosa Arrigo, Kassim Badmus, Francesca Baletto, et al.
Pageof 37

Showing results (351-360 of 363) with videos related to

Sort By:
Pageof 37
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depressionBruce A Dressman, Eric G Tromiczak, Mark D Chappell, et al.
Faraday Discussions|August 11, 2018
Theory as a driving force to understand reactions on nanoparticles: general discussionRosa Arrigo, Kassim Badmus, Francesca Baletto, et al.
Faraday Discussions|June 22, 2016
Designing new catalysts: synthesis of new active structures: general discussionParasuraman Selvam, Joachim Sauer, Bruce Garrett, et al.
Faraday Discussions|July 6, 2021
Thermal catalytic conversion: general discussionKaty Armstrong, Sergio Barbarino, Xiangkun Elvis Cao, et al.
Faraday Discussions|August 10, 2018
Control of catalytic nanoparticle synthesis: general discussionAldiar Adishev, Rosa Arrigo, Francesca Baletto, et al.
Faraday Discussions|June 26, 2023
Heterogeneous catalytic and chemical looping routes to N<sub>2</sub> activation: general discussionFatima Abi Ghaida, Katharina Brinkert, Yongli Cai, et al.
Faraday Discussions|June 29, 2023
Electrocatalytic and photocatalytic routes to N<sub>2</sub> activation: general discussionSuchi Biswas, Katharina Brinkert, Richard A Catlow, et al.
Journal of Medicinal Chemistry|January 21, 2015
Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structuresJames A Monn, Lourdes Prieto, Lorena Taboada, et al.
Faraday Discussions|April 20, 2017
Designing new catalysts for synthetic fuels: general discussionKatherine Holt, Linda Jewell, Hans Niemantsverdriet, et al.
Faraday Discussions|August 11, 2018
The challenges of characterising nanoparticulate catalysts: general discussionRosa Arrigo, Kassim Badmus, Francesca Baletto, et al.
Pageof 37